甲状腺微小髓样癌诊治进展

来源 :中华内分泌外科杂志 | 被引量 : 0次 | 上传用户:markhero
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
甲状腺髓样癌(medullary thyroid cancer,MTC)患者相较于分化型甲状腺癌患者预后较差,手术方式也相对更加激进。但近年来国内外学者发现,甲状腺微小髓样癌(minute-medullary thyroid carcinoma,MMTC)预后似乎相较其他髓样癌的预后更好,也针对其出现了不同的治疗理念。本文选取国内外近几年关于MMTC的相关文献,对MMTC目前的研究进展进行综述。“,”Compared with differentiated thyroid cancer, patients with medullary thyroid cancer have a poor prognosis, and the surgical approach is also more aggressive. However, in recent years, scholars at home and abroad have found that the prognosis ofminute-medullary thyroid carcinoma seems to be better than that of other medullary carcinomas, and different treatment concepts have emerged for it. In this paper, the literatures about medullary thyroid cancer in recent years were selected and the current research progress was reviewed.
其他文献
目的:针对传染性单核细胞增多症患儿,分析应用重组人干扰素α-1b治疗的临床效果.方法:随机选取2019年5月至2020年5月期间在我院进行治疗的传染性单核细胞增多症患儿54例,分为